Biogen Inc (BIIB):企業の財務・戦略的SWOT分析

◆英語タイトル:Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH1307FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Biogen Inc (BIIB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biogen Inc (Biogen) is a biopharmaceutical company that discovers, develops and delivers drugs and biosimilars for the treatment of neurological and neurodegenerative diseases. The company’s marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Fampyra (prolonged-release fampridine tablets) and Plegridy (peginterferon beta-1a) for the treatment of multiple sclerosis (MS); Spinraza (nusinersen) for spinal muscular atrophy (SMA); and Fumaderm (fumaric acid esters) for severe plaque psoriasis. It has several product candidates targeting various indications such as MS, Parkinson’s disease, Alzheimer’s disease and idiopathic pulmonary fibrosis and stroke among others. The company sells its products through direct sales forces, marketing groups and distributors in the Americas, Europe, Asia and other territories. Biogen is headquartered in Cambridge, Massachusetts, the US.

Biogen Inc Key Recent Developments

Feb 11,2021: Biogen and Labcentral Award two golden tickets to local and innovative science startups
Feb 11,2021: Biogen Announces the Expiration Date Results of Its Private Exchange Offer
Feb 11,2021: Bolden Therapeutics receives Biogen-LabCentral ‘Golden Ticket’ award
Feb 05,2021: Biogen offers Arcadia’s home renewable energy program to employees
Feb 03,2021: Biogen reports fourth quarter and full year 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Biogen Inc – Key Facts
Biogen Inc – Key Employees
Biogen Inc – Key Employee Biographies
Biogen Inc – Major Products and Services
Biogen Inc – History
Biogen Inc – Company Statement
Biogen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Biogen Inc – Business Description
Product Category: Biosimilars
Overview
Performance
Product Category: Multiple Sclerosis
Overview
Performance
Product Category: Others
Overview
Performance
Product Category: Spinal Muscular Atrophy
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Performance
Geographical Segment: US
Performance
R&D Overview
Biogen Inc – Corporate Strategy
Biogen Inc – SWOT Analysis
SWOT Analysis – Overview
Biogen Inc – Strengths
Biogen Inc – Weaknesses
Biogen Inc – Opportunities
Biogen Inc – Threats
Biogen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Biogen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Biogen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 11, 2021: Biogen and Labcentral Award two golden tickets to local and innovative science startups
Feb 11, 2021: Biogen Announces the Expiration Date Results of Its Private Exchange Offer
Feb 11, 2021: Bolden Therapeutics receives Biogen-LabCentral ‘Golden Ticket’ award
Feb 05, 2021: Biogen offers Arcadia’s home renewable energy program to employees
Feb 03, 2021: Biogen reports fourth quarter and full year 2020 results
Jan 11, 2021: Biogen to launch pioneering study to develop digital biomarkers of cognitive health using Apple Watch and Iphone
Jan 07, 2021: Sage Therapeutics provides 2021 corporate strategy update at J.P. Morgan Healthcare Conference
Dec 17, 2020: Biogen agrees to pay $22 million to resolve allegations that it paid kickbacks through two co-pay foundations
Dec 17, 2020: Biogen agrees to pay $22 million to resolve alleged false claims act liability for paying kickbacks
Dec 08, 2020: UK Biobank unveils studies to measure circulating protein concentrations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Biogen Inc, Key Facts
Biogen Inc, Key Employees
Biogen Inc, Key Employee Biographies
Biogen Inc, Major Products and Services
Biogen Inc, History
Biogen Inc, Other Locations
Biogen Inc, Subsidiaries
Biogen Inc, Joint Venture
Biogen Inc, Key Competitors
Biogen Inc, Ratios based on current share price
Biogen Inc, Annual Ratios
Biogen Inc, Annual Ratios (Cont...1)
Biogen Inc, Annual Ratios (Cont...2)
Biogen Inc, Interim Ratios
Biogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Biogen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Biogen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Biogen Inc (BIIB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pure Technologies Ltd:企業の戦略的SWOT分析
    Pure Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • McLean Electric Cooperative Inc:企業の戦略的SWOT分析
    McLean Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Tottenham Hotspur Ltd:企業の戦略的SWOT分析
    Tottenham Hotspur Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Gerresheimer AG:戦略・SWOT・企業財務分析
    Gerresheimer AG - Strategy, SWOT and Corporate Finance Report Summary Gerresheimer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Gemalto N.V. (GTO):企業の財務・戦略的SWOT分析
    Gemalto N.V. (GTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • The Kuwait Company for Process Plant Construction & Contracting K.S.C.:企業の戦略・SWOT・財務情報
    The Kuwait Company for Process Plant Construction & Contracting K.S.C. - Strategy, SWOT and Corporate Finance Report Summary The Kuwait Company for Process Plant Construction & Contracting K.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information …
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • InterOil Exploration & Production ASA (IOX):企業の財務・戦略的SWOT分析
    Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, develops and operates oil and natural gas properties, among others. It operates as an active license partner in se …
  • MDNA Life Sciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • Graham Corp (GHM):企業の財務・戦略的SWOT分析
    Summary Graham Corp (Graham) operates as an industrial equipment company that designs and builds vacuum and heat transfer equipment. The company’s products include ejectors, surface condensers, heliflow spiral tube heat exchangers, liquid ring vacuum pumps, process condensers, desuperheaters, and mi …
  • Public Joint-Stock Company Commercial Bank PrivatBank:企業の戦略・SWOT・財務情報
    Public Joint-Stock Company Commercial Bank PrivatBank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank PrivatBank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • BUCA, Inc.:企業の戦略・SWOT・財務情報
    BUCA, Inc. - Strategy, SWOT and Corporate Finance Report Summary BUCA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • numares AG:企業の製品パイプライン分析2018
    Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics. The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein …
  • Crescita Therapeutics Inc (CTX)-製薬・医療分野:企業M&A・提携分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) develops products for the treatment of skin diseases and their symptoms. The company’s product portfolio includes over-the-counter and prescription products such as topical creams. It offers pliaglis, a local anesthetic cream for superficial …
  • Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fujifilm Diosynth Biotechnologies USA Inc (Fujifilm Diosynth), a subsidiary of Fujifilm Corp, is a contract development and manufacturing organization that develops therapeutic products, biologics and vaccines. The organization also develops processes for molecules expressed through fermenta …
  • Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析
    Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • KFG Resources Ltd (KFG):企業の財務・戦略的SWOT分析
    Summary KFG Resources Ltd (KFG) is a petroleum and natural gas exploration company that supplies natural gas. The company produces crude oil and natural gas through its reserves. Its oil and gas reserves are located in Mississippi, Wilcox, and Louisiana. KFG’s Mississippi’s projects comprise Carthag …
  • Shionogi & Co., Ltd.:企業の戦略・SWOT・財務情報
    Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆